During this period, government funding was exceptionally constrained, inadequate and difficult to obtain for the redevelopment of BPL and the production of additional plasma for national self-sufficiency.
Linked evidence
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Self-Sufficiency